Pace Logo

Life Sciences

Pace® Life Sciences Announces Compliant US FDA Inspection of Operations in Oakdale, MN

Proven track record of consistent high quality confirmed at Pace® Life Sciences headquarters MINNEAPOLIS, MN., July 25, 2024 (NEWSWIRE.COM): Pace® Life Sciences, a full-service FDA-registered GMP Analytical Testing laboratory and contract development and manufacturing organization (CDMO) and a Division of Pace®, a Science and Technology Company, announced today a successful inspection from The Food & […]

Pace® Life Sciences Announces Compliant US FDA Inspection of Operations in Oakdale, MN Read More »

Pace® Life Sciences Division Names Dean Bornilla as Head of Commercial

Bornilla brings over 25 years of commercial pharmaceutical experience to Pace® MINNEAPOLIS (July 23, 2024) – Pace® Life Sciences, a full-service contract development and manufacturing organization (CDMO) and a Division of Pace®, a Science and Technology Company, announced today that Dean Bornilla has been named Head of Commercial reporting to Dawn Von Rohr, President, Pace® Life

Pace® Life Sciences Division Names Dean Bornilla as Head of Commercial Read More »

Pace® Life Sciences Announces Successful Outcomes Following US FDA Inspection of Operations in San German, Puerto Rico

Long-standing reputation for robust quality is confirmed as company enters 2024  SAN GERMAN, PR., March 28, 2024 (NEWSWIRE.COM): Pace® Life Sciences, LLC, a full-service FDA-registered central laboratory and contract development and manufacturing organization (CDMO) announced the receipt of an overall positive review from The Food & Drug Administration (FDA), following a three-day general inspection of

Pace® Life Sciences Announces Successful Outcomes Following US FDA Inspection of Operations in San German, Puerto Rico Read More »

Pace® Life Sciences Acquires New Jersey Laboratory from Curia

Former Whitehouse Analytical Laboratory is Now Part of the Pace® Laboratory Network Minneapolis, MN [March 14, 2024] Pace® Life Sciences, LLC, a contract development, and manufacturing organization (CDMO), announced today that it has acquired the Lebanon, New Jersey laboratory facility (formerly Whitehouse Analytical Laboratories) from Curia, a global contract research, development, and manufacturing (CDMO) company.

Pace® Life Sciences Acquires New Jersey Laboratory from Curia Read More »

Pace® Life Sciences Appoints Dawn Von Rohr as Division President

Von Rohr brings over 25 years of experience to company  Pace® Life Sciences, a full-service contract development and manufacturing organization (CDMO) and a Division of Pace®, a Science and Technology Company, announced today that Dawn Von Rohr has been named Division President. Von Rohr will be responsible for driving growth and continued innovations within the Pace®

Pace® Life Sciences Appoints Dawn Von Rohr as Division President Read More »

Crucial Role of Testing Labs in Pipeline Emergency Response

By John Gerken, Vice President of Corporate Accounts and Specialty Analytical Services, Pace  (P&GJ) — Emergency situations, like explosions due to pipeline ruptures, often happen instantly and without warning. Pipeline managers know about the risks that come with the job, but the aftereffects of pipeline ruptures and leaks are often secondary to protecting human life. 

Crucial Role of Testing Labs in Pipeline Emergency Response Read More »

Pace® Life Sciences Adds Liquid Capsule Filling Technology

Pace® Life Sciences continues to make investments to broaden their comprehensive suite of oral solid dose development offerings. ANN ARBOR, Mich., December 19, 2023 (Newswire) – Pace® Life Sciences, a full-service contract development and manufacturing organization (CDMO) and a Division of Pace®, a Science and Technology Company, adds liquid capsule filling technology to their comprehensive suite of

Pace® Life Sciences Adds Liquid Capsule Filling Technology Read More »

Delnova Unveils Partnership With Pace® Life Sciences To Boost Capabilities

DelNova’s partnership will enable clinical development of its lead candidate ReViVox® for the rescue of undesirable outcomes which may arise from a botulinum neurotoxin (BoNT) treatment such as Botox®. Pace® Life Sciences provides a full suite of contract CMC development, clinical trials materials manufacturing, and regulatory compliance, services to the biopharmaceutical industries. SAN DIEGO, Oct.

Delnova Unveils Partnership With Pace® Life Sciences To Boost Capabilities Read More »